CIK 0000908259 · Non-accelerated filer<br>Smaller reporting company
Oncotelic Therapeutics, Inc.
Sign in to watch- Ticker
- OTLC
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 133679168
- Phone
- 650-635-7000
- Business address
- 29397 AGOURA RD., #107, AGUORA HILLS, CA, 91301
- Former names
- MATEON THERAPEUTICS INC, OXIGENE INC
- Open-market buys, last 90 days
- $23,537
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$23,537. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-07-08 | Trieu Vuong CHAIRMAN AND CEO | Grant or award | +259,302 | 90,527,323 | ||
| 2021-07-08 | Trieu Vuong CHAIRMAN AND CEO | Grant or award · Stock Options | +513,953 | 513,953 | ||
| 2021-07-08 | KING STEVEN W Director | Grant or award · Stock Options | +357,412 | 357,412 | ||
| 2021-07-08 | Shah Amit B. CHIEF FINANCIAL OFFICER | Grant or award | +298,837 | 358,837 | ||
| 2021-07-08 | Shah Amit B. CHIEF FINANCIAL OFFICER | Grant or award · Stock Options | +698,256 | 698,256 | ||
| 2021-07-08 | Diamond David Director | Grant or award · Stock Options | +451,467 | 451,467 | ||
| 2021-07-08 | Saund Saran CHIEF BUSINESS OFFICER | Grant or award | +102,519 | 16,457,480 | ||
| 2021-07-08 | Saund Saran CHIEF BUSINESS OFFICER | Grant or award · Stock Options | +216,279 | 216,279 | ||
| 2021-03-31 | MAIDA ANTHONY E III CHIEF CLINICAL OFFICER | Conversion | +938,646 | 1,137,314 | ||
| 2021-03-31 | MAIDA ANTHONY E III CHIEF CLINICAL OFFICER | Conversion · Series A Convertible Preferred Stock | −938 | 0 | ||
| 2021-03-31 | Trieu Vuong CHAIRMAN AND CEO | Conversion | +74,455,719 | 90,268,021 | ||
| 2021-03-31 | Trieu Vuong CHAIRMAN AND CEO | Conversion | +13,849,161 | 16,780,384 | ||
| 2021-03-31 | Trieu Vuong CHAIRMAN AND CEO | Conversion | +5,672,025 | 6,872,529 | ||
| 2021-03-31 | Trieu Vuong CHAIRMAN AND CEO | Conversion · Series A Convertible Preferred Stock | −74,456 | 0 | ||
| 2021-03-31 | Trieu Vuong CHAIRMAN AND CEO | Conversion · Series A Convertible Preferred Stock | −13,849 | 0 | ||
| 2021-03-31 | Trieu Vuong CHAIRMAN AND CEO | Conversion · Series A Convertible Preferred Stock | −5,672 | 0 | ||
| 2021-03-31 | KING STEVEN W Director | Conversion | +3,291,720 | 3,330,647 | ||
| 2021-03-31 | KING STEVEN W Director | Conversion · Series A Convertible Preferred Stock | −3,292 | 0 | ||
| 2021-03-31 | Saund Saran CHIEF BUSINESS OFFICER | Conversion | +16,354,961 | 16,354,961 | ||
| 2021-03-31 | Saund Saran CHIEF BUSINESS OFFICER | Conversion · Series A Convertible Preferred Stock | −16,355 | 0 |
Page 3 of 7 · 140 trades